Osiris Therapeutics, Inc. (OSIR) Stock Discontinues Trial Enrollment

Osiris Therapeutics, Inc. (NASDAQ:OSIR) took it on the chin yesterday morning after the company released news through an 8-K filing.

Keep Reading →